Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (171-180 of 565) with videos related to

Pageof 57
Sort By:
CNS Neuroscience & Therapeutics|August 29, 2009
The impact of nonclinical factors on care use for patients with depression: a STAR*D reportT Michael Kashner, Madhukar H Trivedi, Annie Wicker, et al.
Psychiatric Services (Washington, D.C.)|September 9, 2005
Effect of structured interviews on evaluation time in pediatric community mental health settingsCarroll W Hughes, Graham J Emslie, Hazel Wohlfahrt, et al.
Psychiatric Services (Washington, D.C.)|May 31, 2007
Validity of electronically monitored medication adherence and conventional adherence measures in schizophreniaMatthew J Byerly, Ann Thompson, Thomas Carmody, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 20, 2009
Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patientsRoy H Perlis, Gonzalo Laje, Jordan W Smoller, et al.
Journal of Affective Disorders|May 20, 2014
Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC)Søren D Ostergaard, Per Bech, Madhukar H Trivedi, et al.
Schizophrenia Research|May 30, 2006
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapineMatthew J Byerly, Paul A Nakonezny, Brianne Magouirk Bettcher, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 14, 2013
Association of depressive symptoms with hippocampal volume in 1936 adultsE Sherwood Brown, Carroll W Hughes, Roderick McColl, et al.
Brain Stimulation|October 10, 2025
The trajectory of symptom change over the course of transcranial magnetic stimulation for major depressive disorderLinda L Carpenter, Scott T Aaronson, Todd Hutton, et al.
Journal of Psychiatry & Neuroscience : JPN|February 12, 2002
Quantitative EEG amplitude across REM sleep periods in depression: preliminary reportMarcus P Liscombe, Robert F Hoffmann, Madhukar H Trivedi, et al.
The American Journal of Psychiatry|September 28, 2007
Genetic markers of suicidal ideation emerging during citalopram treatment of major depressionGonzalo Laje, Silvia Paddock, Husseini Manji, et al.
Pageof 57

Showing results (171-180 of 565) with videos related to

Sort By:
Pageof 57
CNS Neuroscience & Therapeutics|August 29, 2009
The impact of nonclinical factors on care use for patients with depression: a STAR*D reportT Michael Kashner, Madhukar H Trivedi, Annie Wicker, et al.
Psychiatric Services (Washington, D.C.)|September 9, 2005
Effect of structured interviews on evaluation time in pediatric community mental health settingsCarroll W Hughes, Graham J Emslie, Hazel Wohlfahrt, et al.
Psychiatric Services (Washington, D.C.)|May 31, 2007
Validity of electronically monitored medication adherence and conventional adherence measures in schizophreniaMatthew J Byerly, Ann Thompson, Thomas Carmody, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 20, 2009
Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patientsRoy H Perlis, Gonzalo Laje, Jordan W Smoller, et al.
Journal of Affective Disorders|May 20, 2014
Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC)Søren D Ostergaard, Per Bech, Madhukar H Trivedi, et al.
Schizophrenia Research|May 30, 2006
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapineMatthew J Byerly, Paul A Nakonezny, Brianne Magouirk Bettcher, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 14, 2013
Association of depressive symptoms with hippocampal volume in 1936 adultsE Sherwood Brown, Carroll W Hughes, Roderick McColl, et al.
Brain Stimulation|October 10, 2025
The trajectory of symptom change over the course of transcranial magnetic stimulation for major depressive disorderLinda L Carpenter, Scott T Aaronson, Todd Hutton, et al.
Journal of Psychiatry & Neuroscience : JPN|February 12, 2002
Quantitative EEG amplitude across REM sleep periods in depression: preliminary reportMarcus P Liscombe, Robert F Hoffmann, Madhukar H Trivedi, et al.
The American Journal of Psychiatry|September 28, 2007
Genetic markers of suicidal ideation emerging during citalopram treatment of major depressionGonzalo Laje, Silvia Paddock, Husseini Manji, et al.
Pageof 57